Skip to main content
OpenTrials
Completed

NCT Number: NCT01738997

Endoscopical Dilation of Benign Esophageal Strictures

Although balloon dilatation is the primary treatment for benign dysphagia, information about the optimal inflation time is lacking. The aim of the current pilot study was to compare 10 seconds inflation time, with 2 minutes inflation time, regarding the efficacy

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Symptomatic dysphagia with an endoscopic picture suggestive of a benign disease

Exclusion criteria

  • Suspicion of achalasia or malignancy. If the patients needed more than 3 dilations the first month this was also a considered an exclusion criterion

Treatment and study plan

Dilation 10 sec

Device

Other names: CRE, Controlled Radial Expansion, Boston Scientific Cork Ltd

Dilation 2 min

Device

Other names: CRE, Controlled Radial Expansion, Boston Scientific Cork Ltd

Primary outcomes

  1. Relief from dysphagia

    Time frame: 1 year from dilation

Sponsors and collaborators

Lead sponsor

University Hospital, Umeå

Other

Collaborators

  • Boston Scientific Corporation
  • Uppsala University

Registry information

Official study title

Endoscopical Dilation of Benign Esophageal Strictures - a Randomized, Clinical Trial, Comparing Two Different Inflation Times.

Important dates

Study start
2003
Primary completion
2006
First posted
Nov 30, 2012
Registry last updated
Nov 30, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.